CFGS
BNTX icon

Concourse Financial Group Securities’s BioNTech BNTX Stock Holding History

Concourse Financial Group Securities’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-166
Closed -$15.3K – 2261
2024
Q2 		$13.3K Hold
166
– – ﹤0.01% 1620
2024
Q1 		$15.3K Buy
166
+35
+27% +$3.36K ﹤0.01% 1580
2023
Q4 		$13.8K Buy
+131
New +$13.2K ﹤0.01% 1592
2021
Q4 		– Sell
-35
Closed -$9.59K – 2378
2021
Q3 		$10K Hold
35
– – ﹤0.01% 1882
2021
Q2 		$8K Hold
35
– – ﹤0.01% 1923
2021
Q1 		$4K Hold
35
– – ﹤0.01% 2002
2020
Q4 		$3K Hold
35
– – ﹤0.01% 2015
2020
Q3 		$2K Buy
+35
New +$2.51K ﹤0.01% 1986

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Concourse Financial Group Securities's BNTX Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 166 shares — an estimated $15.3K sold.

Concourse Financial Group Securities first reported a position in BNTX in Q3 2020 and held it in 8 quarters. The position peaked at $15.3K in Q1 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 166 BioNTech shares in Q3 2024, an estimated $15.3K.
  • Concourse Financial Group Securities first reported a position in BioNTech in Q3 2020 and held it in 8 quarters.
  • Concourse Financial Group Securities's BioNTech position peaked at $15.3K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.